Bone Biologics Corp

Common Stock SEC Reporting - Current
Verified Company Profile 9/12/2017
Contact Info
  • 2 Burlington Woods Drive
  • Ste. 100
  • Burlington, MA 01803

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2017 10-Q
CIK 0001419554
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 3842 - Surgical appliances and supplies
Incorporated In: DE, USA
Year of Inc. 2007
Employees 3 a/o Oct 05, 2016
Company Officers/Contacts
Stephen LaNeve CEO
Jeffrey Frelick COO
Deina Walsh CFO
Company Directors
Bruce Stroever Chairman
John Booth
Jimmy Deshland
Bret Hankey
Service Providers
Accounting/Auditing Firm
Anton & Chia LLP
3501 Jamboree Rd.,
STE 540
Newport Beach, CA, 92660
United States

Legal Counsel
TroyGould PC
1801 Century Park East
Suite 1600
Los Angeles, CA, 90067-2367
United States

Investor Relations Firm
Not Available
BBLG Security Details
Share Structure
Market Value1 $194,995,837 a/o Nov 17, 2017
Authorized Shares 100,000,000 a/o Nov 17, 2017
Outstanding Shares 39,077,322 a/o Nov 17, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.001
Transfer Agent(s) Verified by Transfer Agent
Corporate Stock Transfer, Inc.
Shareholders of Record 48 a/o Mar 30, 2017
Short Selling Data
Short Interest 300 (100%)
Aug 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security